EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Efficacy of endoscopic radiofrequency ablation for proton pump inhibitor‐dependent gastroesophageal reflux disease: Multicenter prospective cohort study

Yuanxi Jiang, Zhiyu Dong, Ying Chen, Huihui Sun, Junwen Wang, Zhenxiang Wang, Qianqian Meng, Han Lin, Qingwei Zhang, Shengliang Chen, Zhizheng Ge, Luowei Wang und 1 weitere

Digestive Endoscopy · 2025

DOI: 10.1111/den.14963 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Digestive Endoscopy, 2025. Verfasst von Yuanxi Jiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tongji Hospital,School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Proton Pump Inhibitors, Radiofrequency Ablation, Catheter Ablation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Innovation Action Plan of STCSM, Shanghai Municipal Health Commission, Clinical Research Plan of SHDC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the effects of endoscopic radiofrequency ablation (RFA) on proton pump inhibitor (PPI)‐dependent gastroesophageal reflux disease (GERD) in a Chinese population, and to explore the factors associated with favorable efficacy.

Methods

A multicenter, single‐armed prospective cohort study was conducted. PPI‐dependent GERD patients were enrolled and underwent RFA. The primary outcome was improvement of GERD health‐related quality of life (GERD‐HRQL). Secondary outcomes were symptom improvement, satisfaction, PPI use, and the indicators of 24‐h pH‐impedance monitoring. A nomogram to predict complete remission was constructed.

Results

In total, 66 patients were included. The GERD‐HRQL score was significantly reduced at the 3 month (mean difference, 14.7 [12.6–16.9]), 6 month (mean difference, 15.9 [13.8–18.1]), 12 month (mean difference, 16.7 [14.4–18.9]), 24 month (mean difference, 18.4 [16.2–20.1]), 36 month (mean difference, 18.2 [16.3–20.4]), and 48 month follow‐up (mean difference, 16.1 [14.2–18.3]), all P < 0.001. The esophageal and extra‐esophageal symptom scores were all significantly decreased. The proportion of satisfaction and no PPI use were significantly higher. With regard to the indicators of 24‐h pH‐impedance monitoring, acid exposure time (AET), and DeMeester score, but not lower esophageal sphincter (LES) pressure, decreased significantly at the 12 month follow‐up. A nomogram based on age, body mass index (BMI), baseline AET, and LES pressure was then constructed and showed good discrimination in the prediction of complete remission following RFA.

Conclusions

This study demonstrated that RFA improved life quality as well as symptoms in PPI‐dependent GERD patients in a Chinese population. Younger age, higher BMI, lower baseline AET, and higher baseline LES pressure indicate favorable efficacy of RFA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastroesophageal RefluxProton Pump InhibitorsRadiofrequency AblationCatheter AblationHumansMaleFemaleProspective StudiesMiddle AgedTreatment OutcomeQuality of LifeAgedAdultEsophageal pH Monitoring

Stichwörter der Autor:innen

GERD‐HRQLdependentendoscopic radiofrequencygastroesophageal reflux diseaseproton pump inhibitor

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Tongji Hospital,School of Medicine, Tongji University, Shanghai, China.
  • Department of Gastroenterology, Digestive Endoscopy Center, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Key Laboratory of Gastroenterology and Hepatology, Division of Gastroenterology and Hepatology, Ministry of Health, Renji Hospital, School of Medicine, Shanghai Institute of Digestive Disease, Shanghai Jiao Tong Univers…

Förderung

  • Science and Technology Innovation Action Plan of STCSM
  • Shanghai Municipal Health Commission
  • Clinical Research Plan of SHDC
  • Shanghai Shenkang Hospital Development Center
  • Shanghai Municipal Hospital Development Center

Zitieren

APA

Jiang, Y., Dong, Z., Chen, Y., Sun, H., Wang, J., Wang, Z., Meng, Q., Lin, H., Zhang, Q., Chen, S., Ge, Z., Wang, L., & Xu, S. (2025). Efficacy of endoscopic radiofrequency ablation for proton pump inhibitor‐dependent gastroesophageal reflux disease: Multicenter prospective cohort study. Digestive Endoscopy. https://doi.org/10.1111/den.14963

Vancouver

Jiang Y, Dong Z, Chen Y, Sun H, Wang J, Wang Z, et al. Efficacy of endoscopic radiofrequency ablation for proton pump inhibitor‐dependent gastroesophageal reflux disease: Multicenter prospective cohort study. Digestive Endoscopy. 2025. doi:10.1111/den.14963

BibTeX
@article{Jiang2025,
  author = {Jiang, Yuanxi and Dong, Zhiyu and Chen, Ying and Sun, Huihui and Wang, Junwen and Wang, Zhenxiang and Meng, Qianqian and Lin, Han and Zhang, Qingwei and Chen, Shengliang and Ge, Zhizheng and Wang, Luowei and Xu, Shuchang},
  title = {Efficacy of endoscopic radiofrequency ablation for proton pump inhibitor‐dependent gastroesophageal reflux disease: Multicenter prospective cohort study},
  journal = {Digestive Endoscopy},
  year = {2025},
  doi = {10.1111/den.14963}
}
Kostenlos starten →